Log in to save to my catalogue

FRI689 First-line F18-choline PET/CT Versus Tc99m-sestaMIBI SPECT/CT In The Surgical Management Of P...

FRI689 First-line F18-choline PET/CT Versus Tc99m-sestaMIBI SPECT/CT In The Surgical Management Of P...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10554557

FRI689 First-line F18-choline PET/CT Versus Tc99m-sestaMIBI SPECT/CT In The Surgical Management Of Primary Hyperparathyroidism: The Multicentre APACH2 Phase III Trial

About this item

Full title

FRI689 First-line F18-choline PET/CT Versus Tc99m-sestaMIBI SPECT/CT In The Surgical Management Of Primary Hyperparathyroidism: The Multicentre APACH2 Phase III Trial

Publisher

US: Oxford University Press

Journal title

Journal of the Endocrine Society, 2023-10, Vol.7 (Supplement_1)

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Disclosure: E. Quak: None. A. Lasne-cardon: None. M. Cavarec: None. B. Lireux: None. V. Bastit: None. N. Roudaut: None. P. Salaun: None. N. Keromnes: None. G. Potard: None. P. Vaduva: None. A. Esvant: None. F. Jegoux: None. O. Crouy-chanel: None. A. Devillers: None. C. Guery: None. C. Lasnon: None. R. Ciappuccini: None. M. Sali dauda: None. B. Legr...

Alternative Titles

Full title

FRI689 First-line F18-choline PET/CT Versus Tc99m-sestaMIBI SPECT/CT In The Surgical Management Of Primary Hyperparathyroidism: The Multicentre APACH2 Phase III Trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10554557

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10554557

Other Identifiers

ISSN

2472-1972

E-ISSN

2472-1972

DOI

10.1210/jendso/bvad114.457

How to access this item